Essential Pro PMCF Study ( rEPIC04E )
NCT05292092
·
clinicaltrials.gov ↗
COMPLETED
Status
161
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease (CAD)
Ischemic Heart Disease
Interventions
DRUG:
Essential pro
Sponsor
Fundación EPIC